| Abstrakt: |
Background: Snakebite envenoming represents a significant and often neglected public health challenge, particularly in rural communities across tropical and subtropical regions. An estimated 1.2–5.5 million people are envenomed by snakebites annually. More than 125,000 of these bites are fatal, and 3–4 times as many results in disability/disfigurement. Despite its prevalence, collecting accurate epidemiological data on snakebite is challenging. This systematic review and meta-analysis collates global epidemiology data on snakebite morbidity and mortality. Methods: Medline, Embase, Cochrane and CINAHL Plus databases were searched for articles published between 2001–2022. Pooled incidence and mortality were obtained using random effects modelling, heterogeneity (I2) was tested, and sensitivity analyses performed. Newcastle-Ottawa Scale assessed study quality. Results: Out of the four databases, 5,312 articles were found. After removing duplicates, 3,953 articles were screened by title and abstract and 65 articles containing information on snakebite epidemiology, encompassing 663,460 snakebites, were selected for analysis. The people most at risk for snakebite were men (59%), engaged in agricultural labour (27.5%), and residing in rural areas (66.7%). More than half (57%) of the reported bites resulted in envenoming. Incidents occurred frequently in the summer season (38.5%), during daytime (56.7%), and bites were most often to the lower limb (56.4%). Envenoming severity was frequently mild (46.7%), treated in hospital (68.3%), and was treated with anti-venom (64.7%). The pooled global incidence and mortality was 69.4 /100,000 population (95%CI: 36.8 to 101.9) and 0.33/100,000 population (95%CI, 0.14 to 0.52) per year, respectively. Stratified by continents, Asia had the highest incidence of 130.7/100,000 population (95%CI: 48.3 to 213.1) while Europe has the lowest with 0.7/100,000 population (95%CI: -0.2 to 1.5). The highest mortality was reported in Asia at 0.96/100,000 population (95% CI: 0.22 to 1.70), and Africa 0.44/100,000 population (95%CI: -0.03 to 0.84). Incidence was highest among inhabitants of lower-middle-income countries 132.7/100,000 population (95%CI: 55.4 to 209.9) while mortality was highest in low-income countries at 0.85/100,000 population (95% CI: -0.06 to 2.31). Conclusion: Incidence and mortality rates noted here highlight the global impact of snakebite and underscore the critical need to address the burden of snakebite envenoming. It also reveals that while reported snakebite incidence was higher in lower-middle-income countries, the burden of mortality was greatest among inhabitants of low-income countries, again emphasising the need for greater efforts to tackle this neglected tropical disease. Author summary: Snakebite envenoming poses a significant public health challenge, especially in rural tropical and subtropical areas. Annually, an estimated 1.2–5.5 million people are envenomed, with over 125,000 fatalities and many more suffering disabilities. Collecting accurate epidemiological data on snakebite is challenging. This systematic review and meta-analysis compile global data on snakebite morbidity and mortality. After screening thousands of articles, 65 were selected, covering 663,460 snakebites. Men in agricultural areas were most at risk, with rural dwellers bearing the brunt. Most bites occurred in summer, during the day, and affected the lower limb. Envenoming severity was typically mild, often treated in hospitals with anti-venom. Globally, the pooled incidence was 69.4/100,000 population per year and mortality was 0.33/100,000 population per year. Asia reported the highest incidence and mortality rates. Incidence was highest in lower-middle-income countries, while mortality was greatest in low-income countries. These findings underscore the urgent need to address the burden of snakebite envenoming, particularly in resource-limited settings. Efforts must focus on prevention, treatment, and strengthening healthcare systems to mitigate the impact of this neglected tropical disease. [ABSTRACT FROM AUTHOR] |
